White House says Trump's deals with pharmaceutical companies offer billions in savings
WASHINGTON (AP) — White House economists estimate that President Donald Trump's deals with pharmaceutical companies to drop some of their U.S. prescription drug prices to what they charge in other countries could save $529 billion over the next 10 years. The analysis obtained by The Associated Press
ORIGINAL SOURCE →via PBS NewsHour
ADVERTISEMENT
⚡ STAY AHEAD
Events like this, convergence-verified across 689 sources, land in your inbox every Sunday. Free.
GET THE SUNDAY BRIEFING →RELATED · US
- [HEALTH] Return on investment of community health workers in the United States: a systematic review.
- [CONFLICT] Trump'a onay oranında keskin düşüş… En sevilmeyen Başkan oldu
- [CONFLICT] Son Dakika... ABD'den 'Hürmüz' açıklaması: 'Çatışmalarda 10 denizci hayatını kaybetti'
- [FINANCE] Hedge fund Citadel 'doubling down' on Miami, CEO Ken Griffin says - Reuters
- [CONFLICT] Beyaz Saray’daki balo salonu inşaatı tartışması büyüyor
- [CONFLICT] ABD Başkanı Trump: İran bizimle anlaşmak istiyor, bu onlar için en doğru adım olacak